Mxi1 inhibitors belong to a specialized class of chemical compounds designed to target and interact with Mxi1, a transcriptional repressor involved in regulating cell growth and differentiation. Mxi1 is a member of the bHLHZip (basic helix-loop-helix leucine zipper) family of transcription factors and plays a critical role in modulating gene expression patterns to maintain cellular homeostasis. The Mxi1 protein interacts with other important transcription factors, such as Myc and Max, forming complexes that can influence gene transcription positively or negatively. The primary goal of Mxi1 inhibitors is to modulate the activity of Mxi1, thereby affecting its interactions with other transcription factors and controlling downstream gene expression. Various classes of Mxi1 inhibitors have been identified and developed, each employing distinct molecular mechanisms to achieve inhibition. Some Mxi1 inhibitors are designed to disrupt the formation of Mxi1-containing transcription factor complexes, hindering its regulatory effects on gene expression. These inhibitors often target specific protein-protein interaction interfaces within the Mxi1 complex, preventing it from exerting its repressive activity.
Alternatively, some Mxi1 inhibitors function as stabilizers of the Mxi1 protein. By increasing the stability of Mxi1, these compounds promote its accumulation within the cell, leading to heightened repression of target genes. In some cases, Mxi1 inhibitors may mimic the binding interfaces of other proteins, such as Myc or Max, which interact with Mxi1. This mimicry can effectively compete for binding sites on Mxi1, disrupting the formation of Myc-Max-Mxi1 complexes and indirectly altering gene expression patterns. The discovery and development of Mxi1 inhibitors have opened new avenues for understanding the intricate regulatory mechanisms governing cell growth and proliferation. By selectively manipulating Mxi1's activity, researchers gain valuable insights into the underlying molecular pathways driving cellular processes. These inhibitors serve as essential research tools in elucidating the roles of Mxi1 in various cellular contexts and disease states. Additionally, exploring the effects of Mxi1 inhibitors contributes to a broader understanding of the complex network of transcriptional regulators.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
10074-G5 | 413611-93-5 | sc-213578 sc-213578B sc-213578A sc-213578C sc-213578D | 5 mg 10 mg 25 mg 100 mg 1 g | $82.00 $154.00 $330.00 $982.00 $2045.00 | 3 | |
This is a small molecule inhibitor that interferes with the interaction between MYC and MXI1, reducing the transcriptional activity of MYC. | ||||||
Reversine | 656820-32-5 | sc-203236 | 5 mg | $221.00 | 13 | |
Originally developed as an Aurora kinase inhibitor, Reversine has also been found to suppress MXI1 expression and promote MYC-dependent apoptosis. | ||||||
BMH-21 | 896705-16-1 | sc-507460 | 10 mg | $165.00 | ||
A small molecule that targets c-MYC by enhancing MXI1 binding to the E-box sequence, repressing c-MYC-mediated gene expression. | ||||||